BCM
BDSI

BTR Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

BTR Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$47K – 170
2019
Q2 		$47K Buy
+10,000
New +$46.6K 0.01% 164

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BTR Capital Management's BDSI Position: Q3 2019 in Review

BTR Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2019, closing a stake of 10,000 shares — an estimated $47K sold.

BTR Capital Management first reported a position in BDSI in Q2 2019 and held it in 1 quarter. The position peaked at $47K in Q2 2019. 119 funds tracked by Wall St. Rank hold BDSI as of Q3 2019.

  • BTR Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2019 after selling out during the quarter.
  • BTR Capital Management sold 10,000 BioDelivery Sciences International, Inc. shares in Q3 2019, an estimated $47K.
  • BTR Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 1 quarter.
  • BTR Capital Management's BioDelivery Sciences International, Inc. position peaked at $47K in Q2 2019.
  • 119 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2019.

Based on BTR Capital Management's 13F filing for Q3 2019, filed 21 Oct 2019.